Avricore Health Inc.
AVCR.V
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 35.26% | 50.58% | 62.61% | 67.34% | 93.90% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 35.26% | 50.58% | 62.61% | 67.34% | 93.90% |
| Cost of Revenue | 25.41% | 29.78% | 49.07% | 45.79% | 70.85% |
| Gross Profit | 53.95% | 103.96% | 93.74% | 123.17% | 160.58% |
| SG&A Expenses | -6.59% | -11.33% | 0.11% | 32.05% | 56.76% |
| Depreciation & Amortization | 29.41% | 102.51% | 110.38% | 225.00% | 440.00% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.36% | 14.34% | 28.11% | 40.04% | 64.50% |
| Operating Income | 130.01% | 120.44% | 107.81% | 60.06% | 13.26% |
| Income Before Tax | 8.83% | 110.32% | 99.37% | 58.99% | 16.84% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 8.83% | 110.32% | 99.37% | 58.99% | 16.84% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 8.83% | 110.32% | 99.37% | 58.99% | 16.84% |
| EBIT | 130.01% | 120.44% | 107.81% | 60.06% | 13.26% |
| EBITDA | 443.49% | 230.03% | 234.98% | 145.53% | 64.47% |
| EPS Basic | 11.54% | 110.81% | 100.00% | 60.32% | 18.75% |
| Normalized Basic EPS | 115.63% | 108.70% | 97.62% | 58.97% | 17.95% |
| EPS Diluted | -25.00% | 105.41% | 94.03% | 53.97% | 12.50% |
| Normalized Diluted EPS | 115.63% | 108.70% | 97.62% | 58.97% | 17.95% |
| Average Basic Shares Outstanding | 0.76% | 0.68% | 0.99% | 1.42% | 1.74% |
| Average Diluted Shares Outstanding | 2.20% | 2.13% | 2.44% | 1.42% | 1.74% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |